Brief: India's Lyka Labs Says Sales Hit, Facing Liquidity Crunch
05/06/2020 07:18
June 5 (Reuters) - Lyka Labs Ltd LYKA.NS :
* PARTIES WHO HAVE PLACED ORDERS HAVE DEFERRED EXECUTION OF
ORDERS; SALES HAS BEEN HIT, FACING LIQUIDITY CRUNCH
Source text for Eikon: ID:nBSE4JwSFS
Further company coverage: LYKA.NS
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Lyka Labs
See all newsBrief: Lyka Labs Gets Tribunal Order To Receive 6.3 Million Rupees From Modi Life Care
Brief: Lyka Labs Gets Indian Patent For Pregabalin Gel 8% Valid Through 2043
India's Lyka Labs secures drug patent for diabetes-related conditions; shares surge
India's Lyka Labs climbs after regulatory body approves Pregabalin Gel
Brief: Lyka Labs Gets Permission From CDSCO To Manufacture, Market Pregabalin Gel 8% W/W In India